As a result of numerous requests to bring this series to the region, September 2013 will see the launch of a specifically tailored event catering to this life science hub. With an agenda covering topics relevant to pharma, biotech, virtual and medical device companies, this event offers a unique opportunity to tailor your visit and take away the most valuable and relevant information and network with specific, high profile contacts.
The event agenda is split so that the first day covers content relevant to biotech and pharma companies, and the second day of the event is divided into two, catering separately to virtual pharma and medical device manufacturers.
Highlights from the agenda include:
- Improving performance throughout your trial by integrating proactive quality management into various stages of your trial
- Negotiating your contract to prioritize and protects your core goals Generating strategies for dealing with a merger or acquisition so as not to disrupt ongoing clinical trials
- Large company capabilities on start‐up company capital constraints: building effective and capable infrastructure for outsourcing clinical trials in the virtual company
- PANEL: Optimizing your selection process to secure the best service provider for your trial
Some of our excellent speakers include:
Doug Lane, President and CEO, Applied Integrin Sciences, Inc
Joe Zimmerman, Sr. Director Clinical Operations, Amylin Pharmaceuticals
Jeff Dahlen, Chief Scientific Officer, Accumetrics
Kenneth Wilson, Director, Business Operations, Pfizer
Chris Airriess, Chief Development Officer, California Stem Cell Inc.
Michael Swit, Special Counsel, FDA Law Practice, Duane Morris LLP
Book your place now here using reference code MK-LEPR1 http://www.spgmediadesign.com/test/arenareg/octsocal/register.asp
Outsourcing in Clinical Trials Southern California, 24-25 September 2013, La Jolla, CA
For more information contact:
E-mail: [email protected]
Telephone: +44 207 936 6948